Unaudited Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Revenue | ||||
| Product revenue, net | $ 14,629,000 | $ 15,279,000 | $ 42,514,000 | $ 44,405,000 |
| Collaboration revenue | 182,000 | 546,000 | ||
| Other revenue | 19,260,000 | 19,519,000 | ||
| Net revenue | 14,629,000 | 34,752,000 | 42,555,000 | 64,567,000 |
| Operating expenses | ||||
| Cost of goods sold - product revenue | 5,285,000 | 6,429,000 | 18,642,000 | 20,645,000 |
| Research and development | 9,446,000 | 20,288,000 | 46,941,000 | 87,702,000 |
| Research and development - licenses acquired | 60,000 | 4,293,000 | ||
| Selling, general and administrative | 21,993,000 | 21,733,000 | 60,867,000 | 71,512,000 |
| Asset impairment | 2,649,000 | 3,143,000 | ||
| Total operating expenses | 36,724,000 | 48,510,000 | 129,099,000 | 187,295,000 |
| Loss from operations | (22,095,000) | (13,758,000) | (86,544,000) | (122,728,000) |
| Other income (expense) | ||||
| Interest income | 589,000 | 547,000 | 2,157,000 | 2,296,000 |
| Interest expense and financing fee | (6,209,000) | (2,534,000) | (10,933,000) | (13,255,000) |
| Gain (loss) on common stock warrant liabilities | 19,000 | 4,542,000 | (578,000) | 10,708,000 |
| Other income (expense) | 1,071,000 | 620,000 | 1,334,000 | (2,049,000) |
| Total other income (expense) | (4,530,000) | 3,175,000 | (8,020,000) | (2,300,000) |
| Loss before income tax expense | (26,625,000) | (10,583,000) | (94,564,000) | (125,028,000) |
| Income tax expense (refund) | 69,000 | 141,000 | (24,000) | 142,000 |
| Net loss | (26,694,000) | (10,724,000) | (94,540,000) | (125,170,000) |
| Net loss attributable to non-controlling interests | 13,827,000 | 5,679,000 | 55,308,000 | 73,812,000 |
| Net loss attributable to Fortress | (12,867,000) | (5,045,000) | (39,232,000) | (51,358,000) |
| Preferred A dividends declared and paid and/or cumulated, and Fortress' share of subsidiary deemed dividends | (2,173,000) | (2,008,000) | (7,006,000) | (6,024,000) |
| Net loss attributable to common stockholders | $ (15,040,000) | $ (7,053,000) | $ (46,238,000) | $ (57,382,000) |
| Net loss per common share attributable to common stockholders - basic | $ (0.76) | $ (0.94) | $ (2.43) | $ (7.94) |
| Net loss per common share attributable to common stockholders - diluted | $ (0.76) | $ (0.94) | $ (2.43) | $ (7.94) |
| Weighted average common shares outstanding - basic | 19,697,290 | 7,498,653 | 19,041,590 | 7,231,004 |
| Weighted average common shares outstanding - diluted | 19,697,290 | 7,498,653 | 19,041,590 | 7,231,004 |
| Related Party | ||||
| Revenue | ||||
| Revenue - related party | $ 31,000 | $ 41,000 | $ 97,000 | |
| X | ||||||||||
- Definition Collaboration revenue. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) on common stock warrant liabilities. No definition available.
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense and amount of debt issuance costs. No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue that is not accounted for under Topic 606. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|